Mathematical Biosciences and Engineering (MBE)

T model of growth and its application in systems of tumor-immune dynamics
Pages: 925 - 938, Issue 3, June 2013

doi:10.3934/mbe.2013.10.925      Abstract        References        Full text (591.0K)           Related Articles

Mohammad A. Tabatabai - Department of Mathematical Sciences, Cameron University, Lawton, OK 73505, United States (email)
Wayne M. Eby - Department of Mathematical Sciences, Cameron University, Lawton, OK 73505, United States (email)
Karan P. Singh - School of Medicine, University of Alabama at Birmingham, Birmingham AL 35294, United States (email)
Sejong Bae - School of Medicine, University of Alabama at Birmingham, Birmingham AL 35294, United States (email)

1 J. C. Arciero, T. L. Jackson and D. E. Kirschner, A mathematical model of tumor-immune evasion and siRNA treatment, Discrete and Continuous Dynamical Systems-Series B, 4 (2004), 39-58.       
2 Ž. Bajzer, T. Carr, D. Dingli and K. Josić, Optimization of tumor virotherapy with recombinant measles viruses, Journal of Theoretical Biology, 252 (2008), 109-122.       
3 J. Burden, J. Ernstberger and K. R. Fister, Optimal control applied to immunotherapy, Discrete and Continuous Dynamical Systems-Series B, 4 (2004), 135-146.       
4 A. Cappuccio, M. Elishmereni and Z. Agur, Cancer immunotherapy by Interleukin-21: Potential treatment strategies evaluated in a mathematical model, Cancer Research, 66 (2006), 7293-7300.
5 F. Castiglione and B. Piccoli, Optimal control in a model of dendritic cell transfection cancer immunotherapy, Bulletin of Mathematical Biology, 68 (2006), 255-274.       
6 A. d' Onofrio, U. Ledzewicz, H. Maurer and H. Schattler, On optimal delivery of combination therapy for tumors, Mathematical Bioscience, 222 (2009), 13-26.       
7 H. P. de Vladar and J. A. González, Dynamic response of cancer under the influence of immunological activity and therapy, Journal of Theoretical Biology, 227 (2004), 335-348.       
8 D. Dingli, M. D. Cascino, K. Josić, S. J. Russell and Ž. Bajzer, Mathematical modeling of cancer radiovirotherapy, Mathematical Biosciences, 199 (2006), 55-78.       
9 W. Eby, M. Tabatabai and Z. Bursac, Hyperbolastic modeling of tumor growth with a combined treatment of iodoacetate and dimethylsulfoxide, BMC Cancer, 10 (2010), 509.
10 M. S. Feizabadi and T. M. Witten, Chemotherapy in conjoint aging-tumor systems: some simple models for addressing coupled aging-cancer dynamics, Theoretical Biology and Medical Modeling, 7 (2010), 21.
11 I. Kareva, F. Berezovskaya and C. Castillo-Chavez, Myeloid cells in tumour-immune interactions, Journal of Biological Dynamics, 4 (2010), 315-327.       
12 D. Kirschner and J. C. Panetta, Modeling immunotherapy of the tumor-immune interaction, Journal of Mathematical Biology, 34 (1998), 235-252.
13 V. A. Kuznetsov, I. A. Makalkin, M. A. Taylor and A. S. Perelson, Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis, Bulletin of Mathematical Biology, 56 (1994), 295-321.
14 U. Ledzewicz, H. Maurer and H. Schättler, Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy, Mathematical Biosciences and Engineering, 8 (2011), 303-323.       
15 U. Ledzewicz, M. Naghnaeian and H. Schättler, "Dynamics of Tumor-Immune Interaction Under Treatment as an Optimal Control Problem," Discrete and Continuous Dynamical Systems, 2011, 971-980.       
16 H. Schättler, U. Ledzewicz and B. Caldwell, Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis, Mathematical Biosciences and Engineering, 8 (2011), 355-369.       
17 M. Simeoni, P. Magni, C. Cammia, G. De Nicolao, V. Croci, E. Pesenti, M. Germani, I. Pogessi and M. Rochetti, Predictive pharmokinetic-pharmodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents, Cancer Research, 64 (2004), 1094-1101.
18 Y. Song, M.-M. Dong and H.-F. Yang, Effects of RNA interference targeting four different genes on the growth and proliferation of nasopharyngeal carcinoma CNE-2Z cells, Cancer Gene Ther., 18 (2006), 297-304.
19 M. Tabatabai, Z. Bursac, W. Eby and K. Singh, Mathematical modeling of stem cell proliferation, Medical & Biological Engineering & Computation, 49 (2011), 253-262.
20 M. Tabatabai, D. K. Williams and Z. Bursac, Hyperbolastic growth models: Theory and application, Theoretical Biological and Medical Modeling, 2 (2005), 1-13.
21 A. Takeda, C. Goolsby and N. R. Yaseen, NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells, Cancer Research, 66 (2006), 6628-6637.
22 K. Tao, M. Fang, J. Alroy and G. G. Sahagian, Imagable 4T1 model for the study of late stage breast cancer, BMC Cancer, 8 (2008), 228.
23 T. Yuri, R. Tsukamoto, K. Miki, N. Uehara, Y. Matsuoka and A. Tsubura, Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells, Oncol. Rep., 16 (2006), 1307-1312.

Go to top